About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalJapan
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
890
By Phase
PHASE3: 1PHASE2: 2
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT01979679Collaborator
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
PHASE3Completed
28 participants
Started: Dec 31, 2008
NCT00409539Collaborator
SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
PHASE2Completed
550 participants
Started: Dec 31, 2006 · Completed: Jul 31, 2008
NCT00296257Lead Sponsor
Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
PHASE2Terminated
312 participants
Started: Feb 28, 2006 · Completed: Apr 30, 2008
Locations (1)
Headquarters
Oita, Japan
Map
Loading map...